The New Jersey Superior Court, Appellate Division dismissed two qui tam lawsuits against Bayer Corp. and Eli Lilly and Co. on March 1 that alleged the companies had violated the New Jersey False Claims Act (NJFC Act) by engaging in unlawful marketing schemes that caused false claims to be submitted to and paid by Medicare and Medicaid (New Jersey v. Health Choice Group, L.L.C.... Read More